At the start of the pandemic, the general unavailability of mainstream supply chain covid testing apparatus combined with an absolute torrent of cash, somewhere around 900 billion in total overall, created a cottage industry in covid testing startups. At the time the institutional thinking was that this was "a good thing" because existing infrastructure had a 0% of meeting covid testing demand. The FDA and other regulators more or less abandoned what little oversight of lab developed tests (LDT) there was during this period. They remain lightly regulated. Fast forward to today, a large number of the covid testing startups still exist and are sitting on mountains of cash, having come up in the age of LDTs they are going to continue to min/max that shaky regulatory framework. People in the startup sphere of influence constantly complain about the FDA being too involved in regulation. LDTs will lead to innovations as well as a abuses, I predict many people will complain their regulation is too lax. Such is the way of trying to regulate anything in healthcare.